In the second new research review on this subject, Assistant Prof. Ibrahim Bitar, Department of Microbiology, Faculty of Medicine and University Hospital in Plzen, Charles University in Prague, Plzen, ...

The gene-editing technique known as CRISPR is promising to revolutionize medicine. Some researchers are trying to help make it available for people with very rare genetic disorders. A gene-editing ...

DUBLIN--(BUSINESS WIRE)--ERS Genomics Limited (‘ERS’) is pleased to announce ATLATL Innovation Centre (‘ATLATL’) as its non-exclusive agent for licensing ERS’ intellectual property for commercial ...

The practice of genetic modification is as old as humanity. For thousands of years, humans have bred crops, livestock and even pets that possess desirable traits. This selective process, which alters ...

Synthego’s CEO and co-founder Paul Dabrowski used to be lead digital designer at SpaceX. Now that he’s applying his engineering talents to intracellular space, he hopes to contribute to dramatic cost ...

Ermias Kebreab, left, and Matthias Hess, right, with the College of Agricultural and Environmental Sciences, will work with UC collaborators to cut methane emissions from cow guts using the ...

It finally happened. About 10 years after being created, gene-editing specialist CRISPR Therapeutics (NASDAQ: CRSP) earned approval for its first therapy late last year. The treatment in question is ...

Crispr gene-editing technology has demonstrated its revolutionary potential in recent years: It has been used to treat rare diseases, to adapt crops to withstand the extremes of climate change, or ...

Detailed price information for Dyadic International (DYAI-Q) from The Globe and Mail including charting and trades.